Infant botulism: case report and clinical update

The American Journal of Emergency Medicine
A Jagoda, G Renner

Abstract

Infant botulism occurs in infants between 1 week and 11 months of age and results from the in vivo production of neurotoxin by Clostridium botulinum. The clinical spectrum ranges from asymptomatic carriers, through various degrees of paralysis, to sudden death. The classic clinical presentation is an afebrile child with constipation and generalized weakness manifested by poor head control, poor suck, and weak cry. Symptoms can progress to include cranial nerve palsies, respiratory arrest, and adynamic ileus. Treatment is supportive in an intensive care setting. Antibiotics and antitoxin are not indicated. The morbidity and mortality is less than 3% in hospitalized patients and complete recovery can be expected. The environmental and dietary factors associated with infection are discussed.

References

May 2, 1977·JAMA : the Journal of the American Medical Association·S S ArnonJ Chin
Feb 1, 1979·The Journal of Pediatrics·S S ArnonJ Chin
Feb 1, 1979·Journal of Clinical Microbiology·T F MiduraS S Arnon
Jun 1, 1979·American Journal of Diseases of Children·R O JohnsonS S Arnon
Aug 1, 1979·Infection and Immunity·L J Moberg, H Sugiyama
Jul 1, 1979·Reviews of Infectious Diseases·D R PetersonN M Chinn
Dec 1, 1979·The Journal of Pediatrics·C L'HommedieuR Polin
Jul 1, 1979·Reviews of Infectious Diseases·S S Arnon, J Chin
Sep 30, 1976·The New England Journal of Medicine·J PickettM A Brunstetter-Shafer
Sep 24, 1976·Science·I KaoD L Price
Apr 1, 1988·Southern Medical Journal·C T GayG B Bobele
Aug 1, 1986·The Journal of Infectious Diseases·S S Arnon
Jul 24, 1986·The New England Journal of Medicine·J K ChiaM Pollack
Oct 1, 1986·American Journal of Diseases of Children·G R IstreR S Hopkins
Aug 1, 1986·The Journal of Infectious Diseases·P AureliC L Hatheway
Jul 1, 1983·Muscle & Nerve·D R CornblathA J Sumner
May 1, 1984·Pediatric Infectious Disease·S S Long
May 1, 1984·Acta paediatrica Scandinavica·N F ButteA S Goldman
Jan 1, 1980·Annual Review of Medicine·S S Arnon
Jan 1, 1981·Epidemiologic Reviews·S S ArnonJ Chin
Apr 1, 1982·The Journal of Pediatrics·S S ArnonJ Chin
Mar 1, 1982·American Journal of Diseases of Children·R E HoffmanM R Skeels

❮ Previous
Next ❯

Citations

Oct 27, 2009·Journal of Pediatric Surgery·Eamon B O'ReillySandra Tomita
Aug 1, 1997·Emergency Medicine Clinics of North America·F LoVecchio, S Jacobson
Nov 1, 1992·Transactions of the Royal Society of Tropical Medicine and Hygiene·S X ZuJ F Li
Nov 1, 1992·The Journal of Emergency Medicine·R D Schmidt, T W Schmidt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Related Papers

Pediatric Radiology
S V Kothare, E G Kassner
Acta Paediatrica Japonica; Overseas Edition
S ToyoguchiK Katou
Reviews of Infectious Diseases
S S Arnon, J Chin
Pediatric Neurology
Christine K FoxJonathan B Strober
© 2021 Meta ULC. All rights reserved